828-24005-08701 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-31
Registered in v-safe
2021-07-31
Dose 1 — Moderna
2021-07-31
Health check-in — day 0, dose 1
Feeling: Poor · Site: Redness · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-08-01
Survey response — days 1–6 daily, dose 1
MedDRA: Tinnitus — Feeling: Fair · Site: Pain, Swelling · Headache · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Pulsatile Tinnitus

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-08-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-08-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-08-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Abdominal pain

Adult check-in
2021-08-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-08-07
Health check-in — day 7, dose 1
Feeling: Good · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-08-14
Survey response — day 14, dose 1
MedDRA: Dyspnoea — Feeling: Fair

Free text: Shortness of breath

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-22
Survey response — day 21, dose 1
MedDRA: Nausea — Feeling: Fair

Free text: Severe Nausea

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-12
Survey response — day 42, dose 1
MedDRA: Nausea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Still extreme nausea

MedDRA releases: 2024-11 · check-in free text available
2022-02-28
Dose 2 — Moderna
2023-03-01
Survey response — 12 months, dose 2
MedDRA: Congenital cystic kidney disease, Grip strength decreased, Pain in extremity, Palpitations — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-03-01
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2023-03-02
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-31	Moderna	No
2	2022-02-28	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 1

2021-08-01

Systemic reaction (other): Pulsatile Tinnitus

Release 9 — day 14, dose 1

2021-08-14

Symptoms: Shortness of breath

Release 9 — day 21, dose 1

2021-08-22

Symptoms: Severe Nausea

Release 9 — day 42, dose 1

2021-09-12

Symptoms: Still extreme nausea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Congenital cystic kidney disease	·	·	✓
SD	Dyspnoea	✓	·	✓
SD	Grip strength decreased	·	·	✓
SD	Nausea	✓	·	✓
SD	Pain in extremity	·	·	✓
SD	Palpitations	·	·	✓
SRO	Tinnitus	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release